1. Visual System: Primary system - optic nerve and visual pathways
2. Central Nervous System: Brain and spinal cord involvement
3. Immune System: Inflammatory response
4. Vascular System: Blood supply to optic nerve

Optic Nerve Structure:

• Length: Approximately 50mm
• Segments:
  • Intraocular (1mm)
  • Intraorbital (25mm)
  • Intracanalicular (5-9mm)
  • Intracranial (10-15mm)

Composition:

• Over 1 million nerve fibers (axons)
• Myelin sheath from oligodendrocytes
• Central retinal artery supply
• Central retinal vein drainage

Visual Pathway:

1. Retina receives light
2. Retinal ganglion cells send axons through optic nerve
3. Optic chiasm (nasal fibers cross)
4. Optic tract
5. Lateral geniculate nucleus (thalamus)
6. Optic radiations
7. Primary visual cortex (occipital lobe)

Anterior Optic Nerve:

• Retinal artery branches
• Choroidal circulation

Posterior Optic Nerve:

• Ophthalmic artery
• Circle of Zinn-Haller

Papillitis (Anterior Optic Neuritis):

• Inflammation of the optic disc
• Visible swelling on fundoscopy
• More common in children
• Often associated with systemic infection

Retrobulbar Neuritis:

• Inflammation behind the eye
• Normal-appearing optic disc initially
• More common in adults
• Often associated with MS

Perineuritis:

• Inflammation of nerve sheath only
• Rare variant
• Different clinical presentation

Demyelinating (Most Common):

• Multiple Sclerosis (MS): Leading cause; 50-70% of cases
• Neuromyelitis Optica Spectrum Disorder (NMOSD): Severe attacks
• Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOG-AD)

Infectious:

• Viral: Measles, mumps, herpes zoster, Epstein-Barr
• Bacterial: Syphilis, Lyme disease, cat scratch
• Fungal: Rare, immunocompromised

Autoimmune/Inflammatory:

• Systemic Lupus Erythematosus
• Sarcoidosis
• Behcet's disease
• Inflammatory Bowel Disease

Other Causes:

• Toxic/Nutritional: Ethambutol, methanol, B12 deficiency
• Radiation: Prior radiation therapy
• Idiopathic: No identifiable cause (20-30%)

• Age: 20-40 years peak incidence
• Gender: Female predominance (3:2)
• Ethnicity: Northern European higher MS risk
• Genetics: HLA-DRB1*15:1 associated with MS

• Smoking: Increases risk and severity
• Vitamin D deficiency: Associated with MS
• Stress: May trigger flares
• Infection: May trigger post-infectious demyelination

Vision Loss:

• Acute onset (hours to days)
• Usually unilateral
• Variable severity (mild to severe)
• Often improves spontaneously

Pain:

• Pain with eye movement (87% of cases)
• Usually precedes or accompanies vision loss
• May be mild to severe
• Typically resolves with vision improvement

Color Vision:

• Desaturation (colors appear less vivid)
• Usually red affected first
• Often the first symptom to improve
• May persist after vision recovery

• Central scotoma: Most common
• Altitudinal defects: Loss above/below fixation
• Arcuate defects: Arch-shaped
• Generalized depression

• Blurred vision (variable)
• Dim vision
• Flashing lights (rare)
• Uhthoff's phenomenon (worsening with heat)

• Limb weakness or numbness
• Sensory changes
• Balance problems
• Bladder dysfunction
• Fatigue

• Bilateral involvement (atypical)
• Severe vision loss
• No pain (atypical)
• Optic disc swelling (needs urgent evaluation)
• Systemic symptoms

Vision Symptoms:

• When did vision loss start?
• How quickly did it progress?
• Is it getting better or worse?
• One eye or both?

Pain:

• Any pain with eye movement?
• Where is the pain located?
• How severe is the pain?

Associated Features:

• Any other neurological symptoms?
• Recent illness?
• Known medical conditions?
• Current medications?

Past History:

• Previous episodes?
• Multiple sclerosis diagnosis?
• Autoimmune conditions?

Visual Acuity:

• Measure each eye separately
• Often reduced in affected eye
• May be 20/20 in mild cases

Color Vision:

• Ishihara plates often abnormal
• Red desaturation common

Pupillary Examination:

• Relative afferent pupillary defect (RAPD)
• Swinging flashlight test

Visual Field Testing:

• Confrontation testing
• Automated perimetry

Fundoscopic Examination:

• May be normal (retrobulbar)
• Disc swelling (papillitis)
• Pallor (chronic)

MRI Brain and Orbits:

• Essential for diagnosis
• Shows optic nerve enhancement
• Rules out other causes
• Assesses MS risk

Blood Tests:

• CBC, ESR, CRP
• Anti-MOG and anti-AQP4 antibodies
• Vitamin B12 level
• Lyme, syphilis serology if indicated
• ANA, ANCA if autoimmune suspected

Lumbar Puncture:

• CSF analysis
• Oligoclonal bands (MS)
• Cell count and protein

NLS Screening:

• Energetic patterns in visual pathway
• Inflammatory markers
• Neurological function
• Immune system assessment

Ayurvedic Assessment:

• Dosha evaluation (Pitta and Vata)
• Systemic inflammation
• Nervous system strength
• Tissue integrity (Dhatu)

• Age >50 without MS risk
• Painless (suggests ischemia)
• Bilateral simultaneously
• Severe vision loss
• No improvement over time

Corticosteroids:

• High-dose IV methylprednisolone
• Oral prednisone taper
• Accelerates recovery (not final outcome)
• Recommended in severe cases

Plasma Exchange:

• For steroid-refractory cases
• NMOSD attacks
• Severe vision loss

• MS disease-modifying therapies
• Reduce attack frequency
• May reduce future optic neuritis risk

• Pain management
• Visual rehabilitation
• Low vision aids if needed

Pitta-Pacifying:

• Cooling herbs and foods
• Avoid spicy and sour
• Triphala for eye health
• Netra Tarpana

Vata-Pacifying:

• Warm, nourishing foods
• Regular routine
• Abhyanga
• Adequate rest

Herbal Support:

• Triphala - eye tonic
• Ashwagandha - adaptogen, nervous system
• Brahmi - cognitive support
• Turmeric - anti-inflammatory

Visual Rest:

• Reduce visual demands
• Avoid prolonged reading
• Use appropriate lighting
• Take frequent breaks

Comfort Measures:

• Cool compresses (if tolerated)
• Gentle eye movement
• Pain management as needed

Lifestyle:

• Adequate sleep
• Stress reduction
• Good nutrition
• Stay hydrated

Visual Rehabilitation:

• Eye exercises (after acute phase)
• Contrast training
• Reading aids if needed

Monitoring:

• Track vision changes
• Note any new symptoms
• Regular follow-up

• Disease-modifying therapy adherence
• Vitamin D optimization
• Stress management
• Infection prevention

• Healthy lifestyle
• Quit smoking
• Adequate vitamin D
• Regular exercise
• Manage stress

Acute Phase:

• Most improvement in first 2-3 weeks
• Continue improving for 6-12 months
• 80-90% achieve 20/40 or better
• Some have persistent deficits

• Color vision abnormalities
• Contrast sensitivity loss
• Visual field defects
• Uhthoff's phenomenon

• 50% develop MS within 15 years
• Optic neuritis may be first attack
• Risk assessment with MRI

Q: Will my vision return to normal after optic neuritis? A: Most patients (80-90%) achieve good vision recovery, often 20/25 or better. However, subtle deficits in color vision, contrast sensitivity, or visual field may persist even with normal acuity.

Q: Does optic neuritis always mean MS? A: No. While MS is the most common cause, approximately 30-50% of optic neuritis cases are not associated with MS. Other causes include other autoimmune conditions, infections, or be idiopathic.

Q: How long does it take to recover from optic neuritis? A: The acute phase typically lasts 1-2 weeks, with improvement beginning within weeks. Most recovery occurs within 3-6 months, though subtle improvements may continue for up to a year.

Q: Can optic neuritis affect both eyes? A: Typically, optic neuritis is unilateral. Bilateral simultaneous optic neuritis is rare and suggests different causes such as autoimmune or inflammatory conditions.

Q: Is treatment always necessary? A: While many cases improve spontaneously, treatment with corticosteroids is often recommended for moderate to severe vision loss to accelerate recovery. The decision depends on severity and underlying cause.

This content is for educational purposes only.